논문KCI 등재
Editor’s Note on Recent Journal Impact Factor of Cancer Research and Treatment
1
조회
0
다운로드
1
인용
0
참고문헌
주제분류의학일반
참고문헌 (1)
관련 논문AI추천
Identifying Trends in Oncology Research through a Bibliographic Analysis of Cancer Research and Treatment김진, 라선영, 안용찬, 이충근, 임채홍, 추정민대한암학회 · Cancer Research and Treatment2025 · 제57권 제1호Correspondence to editorial 1 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 Trial”Ahmed O. Kaseb, Ji Hoon Kim, Ju-Seog Lee, Sung Hwan Lee, Sunyoung S. Lee, Sun Young Yim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Correspondence to editorial 2 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial”Ahmed O. Kaseb, Ji Hoon Kim, Ju-Seog Lee, Sung Hwan Lee, Sunyoung S. Lee, Sun Young Yim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호New Step of Joint Publication with the Korean Association for Clinical Oncology김일한대한암학회 · Cancer Research and Treatment2012 · 제44권 제2호Letter to the editor on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/ bevacizumab failure: A real-world study”Hui-Chin Chang, Meng-Che Wu, Shuo-Yan Gau, Yi-Sheng Jhang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호A novel link between tumor cell metabolism and pa tient prognosis: Editorial on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway”Eun Ji Jang, Pil Soo Sung대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호
이 간행물의 다른 논문 (26건)
HER2-low Breast Cancer: Now and in the Future강소라, 김성배pp. 700-720Clinical Practice Recommendations for the Use of Next-Generation Sequencing in Patients with Solid Cancer: A Joint Report from KSMO and KSP박세훈, 유창훈, 조영미, 김인호, 김형돈, 김한상, 이지은, 정현애, 이혜승, 김시현, 남수정, 김진원, 윤홍석, 이성영, 김지형, 김지현, 이충근, 김한조, 차용준, 김완섭, 전상훈, 심효섭, 임선민, 이인희, 김지훈, 홍숙희, 윤진아, 이아원, 천재경, 박소연, 김미소, 나기용, 윤선옥, 장기택, 박인근, 윤신교, 정재호pp. 721-742Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid TumorsSunil Sharma, 홍용상, 김정은, 류민희, 최창민, 김태원, 류백열, 강윤구, John R. Weis, Rachel Kingsford, Cheol Hee Park, Seong Jang, Arlo McGinn, Theresa L. Wernerpp. 743-750Association of Immune-Related Adverse Events and the Efficacy of Anti-PD-(L)1 Monotherapy in Non-Small Cell Lung Cancer: Adjusting for Immortal-Time BiasWanchen Zhai, Yun Fan, Ying Yu, Hui Li, Ning Chen, Sizhe Yu, Wanji Shenpp. 751-764Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in NSCLC김범석, 김태민, 김미소, 노한성, 김동완, 경동수, 김황필, 김태유, 육정환, 이한백, 임유주, 방두희pp. 765-773